BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22487066)

  • 1. Evaluating agreement regarding the resectability of colorectal liver metastases: a national case-based survey of hepatic surgeons.
    Mohammad WM; Martel G; Mimeault R; Fairfull-Smith RJ; Auer RC; Balaa FK
    HPB (Oxford); 2012 May; 14(5):291-7. PubMed ID: 22487066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of resectability after neoadjuvant chemotherapy for primary non-resectable colorectal liver metastases: A multicenter study.
    Takatsuki M; Tokunaga S; Uchida S; Sakoda M; Shirabe K; Beppu T; Emi Y; Oki E; Ueno S; Eguchi S; Akagi Y; Ogata Y; Baba H; Natsugoe S; Maehara Y;
    Eur J Surg Oncol; 2016 Feb; 42(2):184-9. PubMed ID: 26683263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
    Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
    Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario?
    Sandhu L; Fox A; Nhan C; Barnett H; McLeod RS; Gallinger S; Moulton CA
    HPB (Oxford); 2012 Jun; 14(6):409-13. PubMed ID: 22568418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
    Choti MA; Thomas M; Wong SL; Eaddy M; Pawlik TM; Hirose K; Weiss MJ; Kish J; Green MR
    Ann Surg Oncol; 2016 Feb; 23(2):375-81. PubMed ID: 26561404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
    Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
    HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resectability of colorectal liver metastases: an evolving definition.
    Rocha FG; Helton WS
    HPB (Oxford); 2012 May; 14(5):283-4. PubMed ID: 22487064
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The many faces of ALPPS: surgical indications and techniques among surgeons collaborating in the international registry.
    Buac S; Schadde E; Schnitzbauer AA; Vogt K; Hernandez-Alejandro R
    HPB (Oxford); 2016 May; 18(5):442-8. PubMed ID: 27154808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close collaboration between local and specialist multidisciplinary teams allows 'fast-tracking' of patients with colorectal liver metastases.
    Vasudevan SP; Cresswell AB; Wright JM; Rees M; Stiff D; Wordley A; Motson RW
    Colorectal Dis; 2013; 15(10):1253-6. PubMed ID: 23790093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic colorectal metastases: methods of improving resectability.
    Adam R; Lucidi V; Bismuth H
    Surg Clin North Am; 2004 Apr; 84(2):659-71. PubMed ID: 15062667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Computed tomographic morphological evaluation of neoadjuvant chemotherapy. Effectiveness of the therapy for colorectal liver metastases].
    Folprecht G; Weitz J; Hoffmann RT
    Chirurg; 2014 Jan; 85(1):31-6. PubMed ID: 24366286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.
    Mattar RE; Al-Alem F; Simoneau E; Hassanain M
    World J Gastroenterol; 2016 Jan; 22(2):567-81. PubMed ID: 26811608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making unresectable hepatic colorectal metastases resectable--does it work?
    Vauthey JN; Zorzi D; Pawlik TM
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S118-22. PubMed ID: 16399448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M
    Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.
    Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S
    JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based study on practice variation regarding preoperative systemic chemotherapy in patients with colorectal liver metastases and impact on short-term outcomes.
    Elfrink AKE; Kok NFM; van der Werf LR; Krul MF; Marra E; Wouters MWJM; Verhoef C; Kuhlmann KFD; den Dulk M; Swijnenburg RJ; Te Riele WW; van den Boezem PB; Leclercq WKG; Lips DJ; Nieuwenhuijs VB; Gobardhan PD; Hartgrink HH; Buis CI; Grünhagen DJ; Klaase JM; ;
    Eur J Surg Oncol; 2020 Sep; 46(9):1742-1755. PubMed ID: 32303416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer.
    Wein A; Riedel C; Brückl W; Merkel S; Ott R; Hanke B; Baum U; Fuchs F; Günther K; Reck T; Papadopoulos T; Hahn EG; Hohenberger W
    Oncology; 2003; 64(2):131-8. PubMed ID: 12566910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
    Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
    J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.